TokenPost topic
1 TokenPost story is tagged Biliary tract cancer. The newest appear first.
Median overall survival was 14.9 months with ivonescimab and chemotherapy, versus 12.1 months with durvalumab and chemotherapy in the late-stage trial conducted in China.
Oct 25, 2026, 2:41 PM EDT ยท Business